TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 25.20
-0.90 (-3.45%)
Jul 30, 2026, 11:35 AM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 5.54 billion as of July 29, 2026. Its market cap has increased by 241.65% in one year.
Market Cap
5.54B
Enterprise Value
5.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
25.20
ChartMarket Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has increased from 3.83B to 5.54B, an increase of 44.69%. That is a compound annual growth rate of 3.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 5.48B | 202.94% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.06B |
| Sinphar Pharmaceutical | 6.44B |
| Savior Lifetec | 5.87B |
| TaiGen Biopharmaceuticals Holdings | 5.77B |
| Mycenax Biotech | 5.18B |
| Steminent Biotherapeutics | 5.18B |
| AnnJi Pharmaceutical | 5.14B |
| UnicoCell Biomed | 4.86B |